Ask your eye doctor to do an exam of an eyelash under the microscope to look for Demodex. There are many effective treatments ...

It is caused by bacteria build up at the base of your eyelashes. Treatment for ocular Demodex typically involves an ...

If Demodex mites proliferate too much around ... “For severe face mite overgrowth, a doctor may prescribe topical or oral treatments,” including the topical cream crotamiton or an antibiotic ...

Tarsus Pharmaceuticals sees growth with Xdemvy's $180M sales in 2024. Read this article to know what makes TARS stock a BUY for growth investors.

XDEMVY is indicated for the treatment of Demodex blepharitis. Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side ...

XDEMVY ® (lotilaner ophthalmic solution, 0.25%) is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular ...

Detailed price information for Tarsus Pharmaceuticals Inc (TARS-Q) from The Globe and Mail including charting and trades.